Please assess the completion status of the following clinical trial:

Trial Title: Divalproex vs. Lamotrigine for Bipolar Disorder

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Diagnosis of Bipolar I or Bipolar II disorder~* Prescription of divalproex (any formulation except for Depakene/valproic acid) or lamotrigine in the electronic pharmacy profile.~* Age 19 or older~* Demonstrated stability for at least 4 weeks on an adequate dose of each medication (at least 50mg/d lamotrigine or 15mg/kg/day divalproex).~* Treatment at the TVAMC for at least 6 months following the prescription of divalproex or lamotrigine.~Exclusion Criteria:~* Primary diagnosis of schizoaffective or schizophrenia during the evaluation period.~* Prescription of divalproex and lamotrigine given concurrently during the observation period.~* History of Dementia or cognitive disorders

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).